 |
| Hey, we sent this email earlier today and I just wanted to send it to you again in case you missed it the first time around… Just a reminder that you can get 3 Free Reports that show you the key trends to profit from in the coming months, when you take a no-obligation trial to our outperforming POWR Growth service by @ midnight tonight. So make sure you get started with your 30 day trial today so you don’t miss out! Read on below for more details… ----------------------- Forwarded message ------------------ Dear StockNews Member, Earlier this week I shared my belief that some of your best profits this year will come from high quality Growth Stocks that were dragged down in the 2022 correction. Why? Because now they are trading at more reasonable valuations, these stocks offer the potential for explosive gains as the market continues to recover. But only if you know where to find them… To get you started on the right track I asked my research team to prepare 3 special reports so you can profit from the top growth trends that will lead the charge in the coming months. Each one is packed with in-depth analysis & specific recommendations—and you can get them for FREE, by simply taking a 30 day no-risk trial to our outperforming POWR Growth Newsletter:
EV Battery Technology - With the expectation of electric vehicle production to increase significantly over the next decade, the demand for batteries will similarly skyrocket. Batteries are the most important & costly components of electric vehicles and with technology improving rapidly we see this as the best way to profit from the global shift away from gas power. In this report we take a close look at this expanding industry and give you 5 EV battery stocks perfectly positioned for electrifying gains
Growing Drone Market - Drones have been used since the Vietnam War in a range of combat roles and today are evolving beyond their military origin to become powerful business tools. They’ve already made the leap to the consumer market, and now they're being put to work in commercial applications from firefighting to farming. We look at what this market is projected to be worth in the next 4 years, plus we analyze the leading companies that could deliver your next big profits
Psychedelics - From counter-cultural in the 1960s to mainstream in the 2020s…the psychedelic medicine market is set to be huge. Hallucinogens including psilocybin are showing considerable promise in treating illnesses such as depression and schizophrenia. While psychedelics might seem like an under-the-radar industry now, it won't stay that way for long. In this report we examine how quickly this industry is growing and tell you about 5 promising stocks that could lead you to mind-boggling gains Since launching early last year POWR Growth has greatly outperformed just about every comparable index…including the S&P 500, Russell 2000 and Cathie Wood’s Ark Innovation ETF. That’s not by chance, because it’s backed by our powerful computer-driven Top 10 Growth Stocks strategy with average annual returns of +49.10%. Then our Chief Growth Strategist, Jaimini Desai, uses his expertise to hand pick the very best stocks from this strategy, giving you precise allocations for each and telling you exactly when to sell so you can maximize your gains. The cost for your no-risk trial is just $1 and includes every stock in the current portfolio, all of Jaimini’s top picks over the next month and his in-depth weekly commentary to keep you on the right side of the market action. PLUS the 3 special reports that you get for free, when you start your no risk trial by Sunday May 29th @ midnight. There’s no-obligation beyond the $1 trial, so get started today! Get My 3 Reports & Start 30 Day Trial > > Wishing you a world of investment success!
Steve Reitmeister |
| This email was sent to edwardlorilla1986.paxforex@blogger.com You are receiving this email because you opted in at our website at StockNews.com. StockNews.com 146 W 29th Street, Suite 8E New York, NY 10001 Unsubscribe from this list |
| StockNews.com | Terms of Use | Performance | Privacy Policy |
No comments:
Post a Comment